Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRON
CRON logo

CRON Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.720
Open
2.700
VWAP
2.69
Vol
1.22M
Mkt Cap
1.01B
Low
2.630
Amount
3.27M
EV/EBITDA(TTM)
184.62
Total Shares
373.66M
EV
231.33M
EV/OCF(TTM)
5.95
P/S(TTM)
6.41
Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company's diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.
Show More

Events Timeline

(ET)
2026-06-16
16:30:00
Cronos Group Files Normal Course Issuer Bid
select
2026-05-11 (ET)
2026-05-11
07:50:00
Cronos Reports Q1 Revenue of $45.21M
select
2026-04-23 (ET)
2026-04-23
13:10:00
Roth Capital: Cannabis Products Rescheduled to Schedule 3
select
2026-04-23
10:30:00
Trump Orders Medical Marijuana Products to Schedule III
select
2026-04-23
10:00:00
Trump Signs Order to Reschedule Medical Marijuana to Schedule III
select
link
2026-04-22 (ET)
2026-04-22
12:00:00
Trump Administration Expected to Reclassify Cannabis on Wednesday
select
link
2026-03-19 (ET)
2026-03-19
11:20:00
Representative Proposes Bill to Protect Legal Cannabis Businesses
select
link
2026-03-17 (ET)
2026-03-17
08:50:00
Significant Increases in Borrow Rates Among Liquid Option Names
select

News

Newsfilter
8.0
06-16Newsfilter
Cronos Group Initiates Share Repurchase Program
  • Repurchase Program Launch: Cronos Group has filed a notice of intention for a normal course issuer bid with the Toronto Stock Exchange, which has been accepted, indicating the company's confidence in its stock value as the program commenced on May 14, 2026, and is expected to end on May 13, 2027.
  • Repurchase Scale: The company intends to repurchase up to $50 million of common shares, representing approximately 5.02% of its 373 million issued shares, which is expected to enhance earnings per share and improve shareholder returns.
  • Trading Flexibility: Cronos can execute repurchases through various trading systems, including NASDAQ and other U.S. markets, with a daily limit of 53,968 shares on the TSX, demonstrating its operational flexibility in capital management.
  • Regulatory Exemption: The company received an exemption from the Ontario Securities Commission, allowing it to repurchase shares on U.S. markets beyond the limits set by Canadian law, further strengthening its capital management strategy.
Fool
8.5
06-12Fool
Trulieve Becomes First U.S. Cannabis Company Listed on NYSE
  • Historic Listing: Trulieve successfully listed on the NYSE on June 10, becoming the first U.S. cannabis company on a major exchange, marking a significant milestone for the U.S. cannabis industry and likely attracting increased investor interest.
  • Financial Performance: In its first quarter, Trulieve reported $100 million in adjusted EBITDA, while Tilray expects EBITDA between $62 million and $72 million for the year, highlighting Trulieve's superior profitability.
  • Market Competition: Trulieve and Tilray now compete directly on major exchanges; although Tilray has a broader international presence, Trulieve's vertically integrated model provides better resilience against price fluctuations in the U.S. market.
  • Tax Relief: With the U.S. rescheduling medical marijuana to Schedule III, Trulieve stands to benefit from reduced 280E tax burdens, significantly improving its financial outlook and reinforcing its market position.
NASDAQ.COM
8.5
06-12NASDAQ.COM
Trulieve Lists on NYSE, Competes with Tilray
  • Listing Achievement: Trulieve began trading on the NYSE on June 10, becoming the first U.S. cannabis company to list on a major exchange, marking a significant milestone for the U.S. cannabis industry and potentially attracting more investor interest.
  • Financial Performance Comparison: Trulieve reported $100 million in adjusted EBITDA for Q1, while Tilray expects EBITDA between $62 million and $72 million this year, highlighting Trulieve's clear advantage in profitability.
  • Market Competition Landscape: With 240 dispensaries, Trulieve's operational model allows it to capture the entire retail markup, whereas Tilray, primarily a wholesale manufacturer, faces greater pricing pressure, resulting in significantly lower profit margins compared to Trulieve.
  • Tax Policy Impact: The U.S. reclassification of medical marijuana to Schedule III alleviates Trulieve's 280E tax burden, which is expected to yield substantial financial benefits, further solidifying its leadership position in the market.
Newsfilter
8.5
06-11Newsfilter
Cronos' Spinach® Becomes Top-Selling Vape Brand in Canada
  • Market Share Leadership: Cronos Group's Spinach® vape captured 10.4% of the Canadian vape market in April 2026, maintaining this leading position since January 2026, demonstrating strong consumer appeal and loyalty.
  • Innovation-Driven Products: Spinach® vapes utilize high-purity extracts and advanced hardware to deliver high-quality, flavorful, and consistent experiences for adult consumers, further solidifying its competitive edge in the rapidly growing vape market.
  • New Product Launches: The brand plans to introduce several new SKUs this summer, including three new flavors for the Spinach PUFFERZ™ all-in-one vape and its first limited-time offer Orange Vanilla Twist vape, which is expected to drive sales growth and attract new customers.
  • Global Expansion Strategy: CEO Mike Gorenstein emphasized that Spinach®'s success in Canada validates the effectiveness of its product innovation engine and builds confidence for future expansion of cannabinoid products globally.
stocktwits
5.0
06-05stocktwits
DEA Hearing on Marijuana Rescheduling Sparks Market Optimism
  • Hearing Date Set: The DEA is scheduled to hold a hearing on June 29 to discuss reclassifying marijuana from Schedule I to Schedule III, which could significantly impact commercial and medical uses across the country.
  • Trump Administration Pushes Legislation: The Trump administration is urging Congress to amend the broad ban on hemp-derived products to ensure the legality of CBD products, which is expected to benefit farmers and further fuel market optimism for cannabis stocks.
  • Positive Market Reaction: Following this news, shares of Tilray Brands (TLRY) rose nearly 4% in premarket trading, making it the top-trending ticker on Stocktwits, while peers like Canopy Growth (CGC), Aurora Cannabis (ACB), and Cronos (CRON) also saw their stock prices increase.
  • Investor Sentiment Shift: On Stocktwits, retail sentiment regarding TLRY shifted from 'bullish' to 'extremely bullish', indicating high expectations for the upcoming DEA hearing, which could potentially alter the sentiment curve in the market.
stocktwits
7.0
06-02stocktwits
Andrew Left Convicted of Stock Manipulation Charges
  • Stock Manipulation Conviction: A Los Angeles jury found Andrew Left guilty on 13 counts of stock manipulation between 2018 and 2023, highlighting the severity of his actions in leveraging social media influence for market manipulation, which could result in millions in fines and restitution.
  • Profit Details: Prosecutors revealed that Left earned over $20 million by making bold stock calls on social media while secretly executing opposite trades, raising concerns about market fairness and increasing scrutiny on short sellers from regulators.
  • Citron Research's Response: Following the conviction, Citron Research expressed dissatisfaction with the jury's ruling, arguing that the case could deter honest commentary from investors and market analysts, and pledged to continue fighting for free speech, indicating a commitment to ongoing legal battles.
  • Impact of GameStop Incident: Left's bearish stance on GameStop in 2021 sparked significant retail trading activity; despite the conviction potentially tarnishing his reputation, he plans to short GameStop again in 2024, demonstrating his ongoing engagement with market dynamics.
Wall Street analysts forecast CRON stock price to rise
2 Analyst Rating
Wall Street analysts forecast CRON stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
2.30
Averages
2.72
High
3.14
Current: 0.000
sliders
Low
2.30
Averages
2.72
High
3.14
TD Securities
NULL
to
Buy
maintain
AI Analysis
2026-05-12
Reason
TD Securities
Price Target
AI Analysis
2026-05-12
maintain
NULL
to
Buy
Reason
TD Securities raised the firm's price target on Cronos Group to C$5.50 from C$4.50 and keeps a Buy rating on the shares.
TD Securities
NULL -> Buy
initiated
$4.50
2026-02-24
Reason
TD Securities
Price Target
$4.50
2026-02-24
initiated
NULL -> Buy
Reason
TD Securities initiated coverage of Cronos Group with a Buy rating and C$4.50 price target. Cronos, which has "some of the most iconic Canadian cannabis brands on the market, is well-positioned to improve profitability as it scales the top-line with a lean operating cost base and leading cultivation practices, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CRON
Unlock Now

Valuation Metrics

The current forward P/E ratio for Cronos Group Inc (CRON.O) is 24.88, compared to its 5-year average forward P/E of 380.52. For a more detailed relative valuation and DCF analysis to assess Cronos Group Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
380.52
Current PE
24.88
Overvalued PE
1593.91
Undervalued PE
-832.87

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-2.14
Current EV/EBITDA
-70.94
Overvalued EV/EBITDA
11.87
Undervalued EV/EBITDA
-16.14

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
8.89
Current PS
3.33
Overvalued PS
14.51
Undervalued PS
3.27

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

how is cannibis securities doing today
Intellectia · 8 candidates
Market Cap: >= 100.00MPrice: >= $1.00Themes: The Cannabis IndustryMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
CGC logo
CGC
Canopy Growth Corp
511.04M
TLRY logo
TLRY
Tilray Brands Inc
803.02M
SNDL logo
SNDL
SNDL Inc
391.39M
VFF logo
VFF
Village Farms International Inc
328.97M
ACB logo
ACB
Aurora Cannabis Inc
201.89M
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.49B
Give me the top 5 cannabis companies
Intellectia · 4 candidates
Market Cap: >= 500.00MRevenue Ttm: >= 100.00MRegion: USThemes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.52B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.43B
CRON logo
CRON
Cronos Group Inc
947.63M
TLRY logo
TLRY
Tilray Brands Inc
736.32M
Should I Buy cannabis stocks?
Intellectia · 9 candidates
Market Cap: >= 50.00MThemes: The Cannabis IndustryList Exchange: XNYS, XNASMonthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
what cannabis stocks would you buy?
Intellectia · 4 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryQuarter Revenue Yoy Growth: >= 0.0%Monthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
SNDL logo
SNDL
SNDL Inc
386.25M
ACB logo
ACB
Aurora Cannabis Inc
204.15M
cannabis
Intellectia · 8 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryIs Optionable: TrueMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
best penny stocks to buy
Intellectia · 45 candidates
Market Cap: 50.00M - 1000.00MRegion: USPrice: $0.20 - $5.00Eps Ttm: >= 0Beta: ModerateRisk, HighRiskList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
HIVE logo
HIVE
HIVE Digital Technologies Ltd
695.26M
REI logo
REI
Ring Energy Inc
246.60M
GAU logo
GAU
Galiano Gold Inc
691.04M
LDI logo
LDI
loanDepot Inc
726.45M
ITRG logo
ITRG
Integra Resources Corp
671.92M
MVST logo
MVST
Microvast Holdings Inc
859.84M
marijuana stocks
Intellectia · 8 candidates
Market Cap: >= 200.00MRegion: US, CanadaPrice: >= $1.00Themes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
CGC logo
CGC
Canopy Growth Corp
460.70M
SNDL logo
SNDL
SNDL Inc
406.85M
which. cannabisindustry should I invest in
Intellectia · 2 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryWeekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
whats the best penny stocks to invest into
Intellectia · 25 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Eps Ttm: >= 0Weekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
CRON logo
CRON
Cronos Group Inc
999.35M
GOGO logo
GOGO
Gogo Inc
642.50M
TALK logo
TALK
Talkspace Inc
632.81M
DDL logo
DDL
Dingdong (Cayman) Ltd
602.62M
NPWR logo
NPWR
NET Power Inc
575.35M
VTEX logo
VTEX
VTEX
573.92M
Cannibus stocks
Intellectia · 4 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryBeta: ModerateRisk, HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M

Whales Holding CRON

A
Altria Group, Inc.
Holding
CRON
+17.37%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Cronos Group Inc (CRON) stock price today?

The current price of CRON is 2.71 USD — it has increased 1.5

What is Cronos Group Inc (CRON)'s business?

Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company's diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.

What is the price predicton of CRON Stock?

Wall Street analysts forecast CRON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRON is2.72 USD with a low forecast of 2.30 USD and a high forecast of 3.14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cronos Group Inc (CRON)'s revenue for the last quarter?

Cronos Group Inc revenue for the last quarter amounts to 45.21M USD, increased 40.13

What is Cronos Group Inc (CRON)'s earnings per share (EPS) for the last quarter?

Cronos Group Inc. EPS for the last quarter amounts to 0.04 USD, increased 100.00

How many employees does Cronos Group Inc (CRON). have?

Cronos Group Inc (CRON) has 610 emplpoyees as of June 19 2026.

What is Cronos Group Inc (CRON) market cap?

Today CRON has the market capitalization of 1.01B USD.